These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 35454834)

  • 1. Pancreaticoduodenectomy Is the Best Surgical Procedure for Zollinger-Ellison Syndrome Associated with Multiple Endocrine Neoplasia Type 1.
    Kong W; Albers MB; Manoharan J; Goebel JN; Kann PH; Jesinghaus M; Bartsch DK
    Cancers (Basel); 2022 Apr; 14(8):. PubMed ID: 35454834
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial pancreaticoduodenectomy can provide cure for duodenal gastrinoma associated with multiple endocrine neoplasia type 1.
    Lopez CL; Falconi M; Waldmann J; Boninsegna L; Fendrich V; Goretzki PK; Langer P; Kann PH; Partelli S; Bartsch DK
    Ann Surg; 2013 Feb; 257(2):308-14. PubMed ID: 22580937
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biliary tree gastrinomas in multiple endocrine neoplasia type 1 syndrome.
    Tonelli F; Giudici F; Nesi G; Batignani G; Brandi ML
    World J Gastroenterol; 2013 Dec; 19(45):8312-20. PubMed ID: 24363522
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of Duodenopancreatic Reoperations in Multiple Endocrine Neoplasia Type 1.
    Albers MB; Manoharan J; Bollmann C; Chlosta MP; Holzer K; Bartsch DK
    World J Surg; 2019 Feb; 43(2):552-558. PubMed ID: 30288555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Does the use of routine duodenotomy (DUODX) affect rate of cure, development of liver metastases, or survival in patients with Zollinger-Ellison syndrome?
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2004 May; 239(5):617-25; discussion 626. PubMed ID: 15082965
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcome of duodenopancreatic resections in patients with multiple endocrine neoplasia type 1.
    Bartsch DK; Fendrich V; Langer P; Celik I; Kann PH; Rothmund M
    Ann Surg; 2005 Dec; 242(6):757-64, discussion 764-6. PubMed ID: 16327485
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term results of surgery for pancreatic neuroendocrine neoplasms in patients with MEN1.
    Lopez CL; Waldmann J; Fendrich V; Langer P; Kann PH; Bartsch DK
    Langenbecks Arch Surg; 2011 Dec; 396(8):1187-96. PubMed ID: 21805182
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regression of type II gastric carcinoids in multiple endocrine neoplasia type 1 patients with Zollinger-Ellison syndrome after surgical excision of all gastrinomas.
    Richards ML; Gauger P; Thompson NW; Giordano TJ
    World J Surg; 2004 Jul; 28(7):652-8. PubMed ID: 15383867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biochemically curative surgery for gastrinoma in multiple endocrine neoplasia type 1 patients.
    Imamura M; Komoto I; Ota S; Hiratsuka T; Kosugi S; Doi R; Awane M; Inoue N
    World J Gastroenterol; 2011 Mar; 17(10):1343-53. PubMed ID: 21455335
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pancreatectomy in multiple endocrine neoplasia type 1-related gastrinomas and pancreatic endocrine neoplasias.
    Tonelli F; Fratini G; Nesi G; Tommasi MS; Batignani G; Falchetti A; Brandi ML
    Ann Surg; 2006 Jul; 244(1):61-70. PubMed ID: 16794390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of surgical results in patients with advanced and limited disease with multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome.
    Norton JA; Alexander HR; Fraker DL; Venzon DJ; Gibril F; Jensen RT
    Ann Surg; 2001 Oct; 234(4):495-505; discussion 505-6. PubMed ID: 11573043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term results of a selective surgical approach to management of Zollinger-Ellison syndrome in patients with MEN-1.
    Mortellaro VE; Hochwald SN; McGuigan JE; Copeland EM; Vogel SB; Grobmyer SR
    Am Surg; 2009 Aug; 75(8):730-3. PubMed ID: 19725300
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Surgical management of Zollinger-Ellison syndrome: Classical considerations and current controversies.
    Shao QQ; Zhao BB; Dong LB; Cao HT; Wang WB
    World J Gastroenterol; 2019 Aug; 25(32):4673-4681. PubMed ID: 31528093
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiple endocrine neoplasia type 1 and Zollinger-Ellison syndrome: a prospective study of 107 cases and comparison with 1009 cases from the literature.
    Gibril F; Schumann M; Pace A; Jensen RT
    Medicine (Baltimore); 2004 Jan; 83(1):43-83. PubMed ID: 14747767
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prospective study of surgery for primary hyperparathyroidism (HPT) in multiple endocrine neoplasia-type 1 and Zollinger-Ellison syndrome: long-term outcome of a more virulent form of HPT.
    Norton JA; Venzon DJ; Berna MJ; Alexander HR; Fraker DL; Libutti SK; Marx SJ; Gibril F; Jensen RT
    Ann Surg; 2008 Mar; 247(3):501-10. PubMed ID: 18376196
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of sporadic and multiple endocrine neoplasia type 1 gastrinomas.
    Fendrich V; Langer P; Waldmann J; Bartsch DK; Rothmund M
    Br J Surg; 2007 Nov; 94(11):1331-41. PubMed ID: 17939142
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Case report: optimal tumor cytoreduction and octreotide with durable disease control in a patient with MEN-1 and Zollinger-Ellison syndrome-over a decade of follow-up.
    Daniels LM; Khalili M; Morano WF; Simoncini M; Mapow BC; Leaf A; Bowne WB
    World J Surg Oncol; 2019 Dec; 17(1):213. PubMed ID: 31818296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Patients with multiple endocrine neoplasia type 1 with gastrinomas have an increased risk of severe esophageal disease including stricture and the premalignant condition, Barrett's esophagus.
    Hoffmann KM; Gibril F; Entsuah LK; Serrano J; Jensen RT
    J Clin Endocrinol Metab; 2006 Jan; 91(1):204-12. PubMed ID: 16249283
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sporadic versus hereditary gastrinomas of the duodenum and pancreas: distinct clinico-pathological and epidemiological features.
    Anlauf M; Garbrecht N; Henopp T; Schmitt A; Schlenger R; Raffel A; Krausch M; Gimm O; Eisenberger CF; Knoefel WT; Dralle H; Komminoth P; Heitz PU; Perren A; Klöppel G
    World J Gastroenterol; 2006 Sep; 12(34):5440-6. PubMed ID: 17006979
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.